RAC (Risk Assessment Committee)

RAC is ECHA’s Risk Assessment Committee, responsible for preparing scientific opinions on: restriction proposals under Annex XVII; authorisation applications and review reports; and substance evaluation conclusions. RAC assesses the risks to human health and the environment and evaluates whether proposed restrictions or conditions are appropriate to adequately control identified risks. RAC opinions feed into the European Commission’s final decisions on restrictions and authorisations.

REACH Regulation (EC) No 1907/2006, Articles 77(3) and 64(4); ECHA Rules of Procedure.

RAC opinions are publicly available on the ECHA website and represent the current scientific consensus on risk management for the relevant substance or use. Companies whose substances are subject to RAC review should engage with the public consultation process, providing data on use conditions, exposure levels, and available alternatives. RAC opinions can include conditions or time-limited authorisations that directly affect downstream use rights.